Abeona Therapeutics (ABEO) Revenue (2011 - 2026)

Abeona Therapeutics' Revenue history runs 13 years deep, the most recent figure standing at $8.7 million for Q1 2026.

• In Q1 2026, Revenue changed N/A year-over-year to $8.7 million; the TTM figure through Mar 2026 stood at $14.5 million (changed N/A YoY), while the FY2025 annual figure was $5.8 million, changed N/A from the prior year.
• Revenue was $8.7 million for Q1 2026 at Abeona Therapeutics, up from $5.4 million in the prior quarter.
• In the past five years, Revenue ranged from a high of $8.7 million in Q1 2026 to a low of $68000.0 in Q4 2022.
• Historically, Revenue has averaged $2.8 million across 4 years, with a median of $1.0 million in 2022.
• Biggest YoY gain for Revenue was 250.0% in 2023; the steepest drop was 250.0% in 2023.
• A 4-year view of Revenue shows it stood at $68000.0 in 2022, then surged by 5047.06% to $3.5 million in 2023, then surged by 54.86% to $5.4 million in 2025, then surged by 60.89% to $8.7 million in 2026.
• The last three Revenue figures came in at $8.7 million (Q1 2026), $5.4 million (Q4 2025), and $400000.0 (Q2 2025), per Business Quant data.